| Literature DB >> 33175348 |
Lyndsey M Hornbuckle1, Amy Rauer2, Kerri M Winters-Stone3, Cary Springer4, Chloe S Jones5, Lindsay P Toth6.
Abstract
BACKGROUND: African-Americans (AAs) have higher rates of inactivity, obesity, and cardiometabolic risk compared to other races/ethnicities. Romantic partners can positively influence health habits, yet whether or not couples have to exercise together in order to adopt regular exercise remains unclear. This study examined whether exercising together influences exercise adherence and cardiometabolic risk in AA couples.Entities:
Keywords: Cultural relevance; Intervention; Marriage; Older adults; Resistance training; Walking
Mesh:
Year: 2020 PMID: 33175348 PMCID: PMC7657066 DOI: 10.1007/s40615-020-00912-6
Source DB: PubMed Journal: J Racial Ethn Health Disparities ISSN: 2196-8837
Fig. 1Flow diagram of participant progression through the study. AA = African-American; PA = physical activity; ET = group exercised together; ES = group exercise separately
Baseline descriptive characteristics of participants who entered the study (n = 28)
| Variables | Women ( | Men ( | All ( | Range |
|---|---|---|---|---|
| Age (years) | 61.2 ± 9.5 | 62.9 ± 9.6 | 62.0 ± 9.4 | 40.6–74.8 |
| Height (m) | 164.8 ± 5.9 | 180.5 ± 9.2 | 172.7 ± 11.0 | 154.5–195.0 |
| Weight (kg) | 85.8 ± 15.4 | 103.4 ± 19.2 | 94.6 ± 19.3 | 57.0–147.0 |
| Body mass index (kg/m2) | 31.4 ± 4.6 | 31.7 ± 5.2 | 31.6 ± 4.8 | 23.1–42.7 |
| Waist circumference (cm) | 93.5 ± 8.2 | 104.4 ± 9.7 | 98.9 ± 10.4 | 78.8–121.8 |
| Hip circumference (cm) | 113.9 ± 12.0 | 113.7 ± 11.2 | 113.8 ± 11.4 | 93.8–144.3 |
| Body fat (%) | 44.1 ± 4.5 | 34.4 ± 5.8 | 39.3 ± 7.1 | 24.8–50.8 |
| Total fat mass (kg) | 38.3 ± 9.2 | 36.3 ± 11.2 | 37.3 ± 10.1 | 17.8–59.5 |
| Total lean mass (kg) | 99.5 ± 15.3 | 140.4 ± 21.6 | 119.9 ± 27.8 | 75.3–186.1 |
| Android fat (%) | 51.8 ± 6.7 | 46.0 ± 8.1 | 48.9 ± 7.9 | 29.9–60.9 |
| Gynoid fat (%) | 46.4 ± 5.0 | 34.6 ± 6.0 | 40.5 ± 8.1 | 25.7–57.8 |
| Systolic BP (mmHg) | 139.5 ± 17.0 | 136.8 ± 14.3 | 138.1 ± 15.5 | 115.3–169.8 |
| Diastolic BP (mmHg) | 84.9 ± 11.2 | 82.6 ± 6.5 | 83.7 ± 9.1 | 68.5–104.5 |
| Glucose (mg/dL) | 95.1 ± 17.0 | 101.8 ± 15.8 | 98.4 ± 16.5 | 71.0–142.0 |
| Insulin (μIU/mL) | 15.2 ± 9.1 | 17.1 ± 11.5 | 16.1 ± 10.2 | 3.8–38.6 |
| HOMA-IR | 3.3 ± 1.9 | 3.4 ± 2.4 | 3.3 ± 2.1 | 0.7–8.2 |
| Hemoglobin A1c (%) | 5.8 ± 0.7 | 6.5 ± 3.8 | 6.1 ± 2.7 | 0.6–18.5 |
| Triglycerides (mg/dL) | 98.8 ± 56.5 | 106.8 ± 44.9 | 103.0 ± 50.0 | 32–212 |
| HDL cholesterol (mg/dL) | 69.5 ± 17.2 | 51.8 ± 14.2 | 60.3 ± 17.9 | 34–91 |
| Total cholesterol (mg/dL) | 177.7 ± 27.9 | 200.5 ± 52.9 | 188.7 ± 42.6 | 129–313 |
| C-reactive protein (mg/L) | 6.7 ± 9.7 | 3.1 ± 3.1 | 4.9 ± 7.3 | 0.3–30.3 |
| Fibrinogen (mg/dL) | 336.3 ± 45.2 | 325.6 ± 67.4 | 331.0 ± 56.6 | 223–436 |
| Average baseline steps/day | 6021 ± 1342 | 5927 ± 1797 | 5974 ± 1557 | 2131–7942 |
Values presented as mean ± SD
Baseline steps were averaged over a 7-day period at the beginning of the study
BP blood pressure; HOMA-IR homeostatic model assessment-estimated insulin resistance; HDL high-density lipoprotein
Summary of exercise adherence in study completers (n = 18)
| Variables | Exercised together ( | Exercised separately ( |
|---|---|---|
| Self-reported walking | ||
| Exact prescriptiona | ||
| Average percent of weekly adherence (%) | 39.1 ± 32.9 | 30.2 ± 35.3 |
| Average walking (minutes/week) | 86.5 ± 57.7 | 66.1 ± 31.7 |
| Total walking time over 12 weeks (minutes) | 842.3 ± 285.4 | 722.8 ± 427.8 |
| Overallb | ||
| Average percent of weekly adherence (%) | 55.0 ± 32.0 | 37.5 ± 35.4 |
| Average walking (minutes/week) | 85.5 ± 58.1 | 65.0 ± 31.5 |
| Total walking time over 12 weeks (minutes) | 1009.8 ± 275.7 | 768.4 ± 435.7 |
| Resistance training | ||
| Percent resistance training session attendance out of 24 sessions (%) | 88.7 ± 6.7 | 95.4 ± 7.8 |
There were no significant differences between groups (P < 0.05)
aExact walking prescription defined as ≥ 30 min on at least 3 days/week with (ET) or without (ES) the study partner
bOverall walking prescription defined as ≥ 90 min, regardless of partner participation
Variable comparisons of study completers adjusted by gender (n = 18)
| Exercised together ( | Exercised separately ( | Overall | ||||
|---|---|---|---|---|---|---|
| Variables | PRE | POST | PRE | POST | PRE (95% CI) | POST (95% CI) |
| Strength and objective physical activity | ||||||
| Upper body strength (kg) | 37.0 ± 4.1 | 45.5 ± 4.1 | 40.1 ± 4.6 | 47.2 ± 4.6 | 38.6 ± 3.1 (32.0–45.1) | 46.3 ± 3.1 (39.8–52.8) ** |
| Lower body strength (kg) | 104.5 ± 7.3 | 122.3 ± 7.3 | 110.2 ± 2.6 | 118.0 ± 8.5 | 107.4 ± 5.4 (96.1–118.6) | 120.0 ± 5.6 (108.6–131.7) * |
| Average steps/day | 6172 ± 567 | 6184 ± 567 | 6013 ± 634 | 6403 ± 754 | 6092 ± 425 (5210–6975) | 6293 ± 472 (5322–7264) |
| Body composition variables | ||||||
| Weight (kg) | 94.9 ± 4.7 | 94.8 ± 4.7 | 85.8 ± 5.2 | 86.4 ± 5.2 | 90.4 ± 3.5 (82.9–97.8) | 90.6 ± 3.5 (83.2–98.1) |
| Body mass index (kg/m2) | 31.9 ± 1.4 | 31.9 ± 1.4 | 29.7 ± 1.6 | 29.9 ± 1.6 | 30.7 ± 1.1 (28.5–33.1) | 30.9 ± 1.1 (28.6–33.2) |
| Waist circumference (cm) | 98.0 ± 2.6 | 96.6 ± 2.6 | 96.2 ± 2.9 | 94.6 ± 2.9 | 97.1 ± 2.0 (92.9–101.2) | 95.6 ± 2.0 (91.4–99.8) ** |
| Hip circumference (cm) | 114.4 ± 3.0 | 113.1 ± 3.0 | 108.3 ± 3.4 | 107.6 ± 3.4 | 111.3 ± 2.2 (106.6–116.1) | 110.3 ± 2.2 (105.5–115.1) |
| Body fat (%) | 39.5 ± 1.7 | 39.2 ± 1.7 | 37.0 ± 1.9 | 35.9 ± 1.9 | 38.3 ± 1.2 (35.6–40.9) | 37.6 ± 1.2 (34.9–40.2) * |
| Total fat mass (kg) | 37.6 ± 2.8 | 37.0 ± 2.8 | 31.9 ± 3.1 | 31.0 ± 3.1 | 34.7 ± 2.1 (30.3–39.2) | 34.0 ± 2.1 (29.6–38.4) ** |
| Total lean mass (kg) | 53.3 ± 2.3 | 54.5 ± 2.3 | 51.0 ± 2.6 | 51.9 ± 2.6 | 52.1 ± 1.8 (48.4–55.8) | 53.2 ± 1.8 (49.5–56.9) |
| Android fat (%) | 49.2 ± 2.5 | 49.9 ± 2.5 | 46.3 ± 2.8 | 45.1 ± 2.8 | 47.7 ± 1.9 (43.8–51.7) | 47.5 ± 1.9 (43.6–51.5) |
| Gynoid fat (%) | 41.1 ± 1.5 | 40.7 ± 1.5 | 37.5 ± 1.6 | 36.7 ± 1.6 | 39.3 ± 1.1 (37.0–41.7) | 38.7 ± 1.1 (36.3–41.0) * |
| Cardiometabolic risk factors | ||||||
| Systolic BP (mmHg) | 141.2 ± 5.2 | 138.4 ± 5.2 | 140.1 ± 5.9 | 136.5 ± 5.9 | 140.6 ± 3.9 (132.4–148.9) | 137.5 ± 3.9 (129.2–145.7) |
| Diastolic BP (mmHg) | 83.3 ± 3.5 | 82.2 ± 3.5 | 84.7 ± 4.0 | 83.3 ± 4.0 | 84.0 ± 2.7 (78.4–89.6) | 82.7 ± 2.7 (77.1–88.4) |
| Glucose (mg/dL) | 91.1 ± 4.2 | 94.9 ± 4.2 | 97.3 ± 4.7 | 94.5 ± 4.7 | 94.2 ± 3.2 (87.6–100.8) | 94.7 ± 3.2 (88.1–101.3) |
| Insulin (μIU/mL) | 14.4 ± 2.8 | 15.0 ± 2.8 | 14.3 ± 3.1 | 14.2 ± 3.1 | 14.4 ± 2.1 (10.0–18.7) | 14.6 ± 2.1 (10.3–19.0) |
| HOMA-IR | 3.2 ± 0.8 | 3.5 ± 0.8 | 3.7 ± 0.8 | 3.5 ± 0.8 | 3.5 ± 0.6 (2.3–4.6) | 3.5 ± 0.6 (2.3–4.6) |
| Hemoglobin A1c (%) | 5.8 ± 0.1 | 5.8 ± 0.1 | 6.0 ± 0.6 | 5.7 ± 0.6 | 5.9 ± 0.1 (5.7–6.1) | 5.7 ± 0.1 (5.5–6.0) * |
| Triglycerides (mg/dL) | 96.8 ± 14.6 | 109.4 ± 14.6 | 80.5 ± 17.0 | 93.3 ± 16.3 | 88.7 ± 11.2 (65.3–112.0) | 101.3 ± 11.0 (78.5–124.2) |
| HDL cholesterol (mg/dL) | 59.2 ± 4.7 | 54.2 ± 4.7 | 64.2 ± 5.5 | 57.8 ± 5.3 | 61.7 ± 3.6 (54.2–69.2) | 56.0 ± 3.5 (48.6–63.4) * |
| Total cholesterol (mg/dL) | 182.2 ± 13.9 | 190.0 ± 13.9 | 185.0 ± 15.6 | 182.3 ± 15.6 | 183.6 ± 10.4 (161.7–205.6) | 186.1 ± 10.4 (164.2–208.1) |
| C-reactive protein (mg/L) | 2.4 ± 1.6 | 2.2 ± 1.6 | 4.9 ± 1.7 | 4.1 ± 1.7 | 3.6 ± 1.2 (1.2–6.1) | 3.1 ± 1.7 (0.7–5.6) |
| Fibrinogen (mg/dL) | 337.3 ± 17.4 | 324.7 ± 17.9 | 319.9 ± 19.5 | 307.3 ± 19.5 | 328.6 ± 13.1 (301.2–356.0) | 316.0 ± 13.2 (288.3–343.7) |
Values presented as estimated marginal means ± SE adjusted by gender
Baseline steps were averaged over a 7-day period at the beginning of the study. Post-intervention steps were an average of weeks 11 and 12 of the intervention
There were no significant differences between groups at baseline for any variable
There were no significant group × time interactions
PRE pre-intervention/baseline; POST post-intervention, 12 weeks after baseline; BP blood pressure; HOMA-IR homeostatic model assessment-estimated insulin resistance; HDL high-density lipoprotein
*Statistically significant time effect from pre- to post-intervention (P < 0.05)
**Statistically significant time effect from pre- to post-intervention (P < 0.01)